Clinical Trial Update: Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for early administration of Cerebrolysin in acute ischemic stroke patients undergoing EVT (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Acute Ischemic

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Pomeranian Medical University Szczecin | Conditions: Stroke, Acute, Ischemic | Phase 2, Phase 3 | Status: UNKNOWN